Caricamento...
α(1)-Antitrypsin deficiency · 5: Intravenous augmentation therapy: current understanding
The biochemical and clinical efficacy of intravenous augmentation therapy in α(1)-antitrypsin deficiency is reviewed, adverse events experienced with this treatment are considered, and its cost effectiveness is discussed.
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Group
2004
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1747086/ https://ncbi.nlm.nih.gov/pubmed/15282394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thx.2003.006544 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|